ALFA Filings
Every announcement, straight from the exchange
Every Dr. Reddy's Laboratories financial results announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Dr. Reddy's Laboratories Ltd reported revenue from operations of ₹8,698 Cr (-1.5% YoY) and net profit of ₹913.2 Cr (-31.7% YoY) for Q2 FY27.
Dr. Reddy's Laboratories Ltd reported revenue from operations of ₹8,100 Cr (-5.5% YoY) and net profit of ₹435.6 Cr (-69.1% YoY) for Q1 FY27.
Dr. Reddy's Laboratories Ltd reported revenue from operations of ₹7,546 Cr (-11.5% YoY) and net profit of ₹221.3 Cr (-86.1% YoY) for Q4 FY26.
Dr. Reddy's Laboratories reported FY26 consolidated revenue of ₹33,593.3 Crore and recommended a ₹8 dividend per share. Performance reflects lower generic sales and one-time impact costs.
Dr. Reddy's Laboratories Ltd reported net profit of ₹1,190 Cr (-15.2% YoY) for Q3 FY26.